Immunoadsorption and Covid 19 Pandemic

Overview

Journal Transfus Apher Sci

Specialty Hematology

Date 2022 Nov 13

PMID 36372733

Authors

Paraskevi Tseke

Ioannis Griveas

Affiliations

Soon will be listed here.

Citing Articles

THSD7A as a Promising Biomarker for Membranous Nephrosis.

Jiang S, Jiang D, Lian Z, Huang X, Li T, Zhang Y Mol Biotechnol. 2023; 66(11):3117-3135.

PMID: 37884765 DOI: 10.1007/s12033-023-00934-5.

References

Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M . Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PLoS One. 2018; 13(3):e0193672. PMC: 5854315. DOI: 10.1371/journal.pone.0193672. View

Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B . Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion. Blood. 2020; 136(6):755-759. PMC: 7414593. DOI: 10.1182/blood.2020007079. View

. Long COVID: let patients help define long-lasting COVID symptoms. Nature. 2020; 586(7828):170. DOI: 10.1038/d41586-020-02796-2. View

Bose S, Adapa S, Aeddula N, Roy S, Nandikanti D, Vupadhyayula P . Medical Management of COVID-19: Evidence and Experience. J Clin Med Res. 2020; 12(6):329-343. PMC: 7295552. DOI: 10.14740/jocmr4201. View

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-768. PMC: 7108125. DOI: 10.1093/cid/ciaa248. View

Braun N, Risler T . Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease. Ther Apher. 1999; 3(3):240-5. DOI: 10.1046/j.1526-0968.1999.00155.x. View

Kuster G, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P . SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?. Eur Heart J. 2020; 41(19):1801-1803. PMC: 7184407. DOI: 10.1093/eurheartj/ehaa235. View

Rothenburg J, Rink-Baron S, Mueller L, Ostermann P, Fischer J, Stegbauer J . COVID-19 antibody donation using immunoadsorption: Report of two cases. Transfus Apher Sci. 2021; 60(5):103193. PMC: 8205282. DOI: 10.1016/j.transci.2021.103193. View

Huang Q, Xiong H, Yan P, Shuai T, Liu J, Zhu L . The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis. Shock. 2019; 53(4):416-425. PMC: 7069396. DOI: 10.1097/SHK.0000000000001434. View

10.

Lin M, Sun B, Liu Z, Tang P, Zhang L, Wang Y . Evaluation of the clinical diagnostic value of traditional inflammatory markers and novel biomarkers in intracellular bacterial bloodstream infections. Cytokine. 2020; 136:155238. DOI: 10.1016/j.cyto.2020.155238. View

11.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

12.

Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z . The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020; 214:108393. PMC: 7102614. DOI: 10.1016/j.clim.2020.108393. View

13.

Bloch E, Shoham S, Casadevall A, Sachais B, Shaz B, Winters J . Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020; 130(6):2757-2765. PMC: 7259988. DOI: 10.1172/JCI138745. View

14.

Sanchez A, Cunard R, Ward D . The selective therapeutic apheresis procedures. J Clin Apher. 2013; 28(1):20-9. DOI: 10.1002/jca.21265. View

15.

Bornstein S, Voit-Bak K, Donate T, Rodionov R, Gainetdinov R, Tselmin S . Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?. Mol Psychiatry. 2021; 27(1):34-37. PMC: 8209771. DOI: 10.1038/s41380-021-01148-4. View

16.

Alwan N . Track COVID-19 sickness, not just positive tests and deaths. Nature. 2020; 584(7820):170. DOI: 10.1038/d41586-020-02335-z. View

17.

Del Rosso M, Margheri F, Serrati S, Chilla A, Laurenzana A, Fibbi G . The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. Curr Pharm Des. 2011; 17(19):1924-43. DOI: 10.2174/138161211796718189. View

18.

Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi K, Takano T . Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. 2003; 12(2):225-30. View

19.

Kim J, Abdullayev N, Neuneier J, Fink G, Lehmann H . Post-COVID-19 encephalomyelitis. Neurol Res Pract. 2021; 3(1):18. PMC: 7957276. DOI: 10.1186/s42466-021-00113-4. View

20.

Azam T, Shadid H, Blakely P, OHayer P, Berlin H, Pan M . Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. J Am Soc Nephrol. 2020; 31(11):2725-2735. PMC: 7608953. DOI: 10.1681/ASN.2020060829. View